Filter
301
Text search:
substandard
medicines
Featured
Recommendations
23
New Publications
100
Language
Document type
No document type
152
Studies & Reports
63
Guidelines
33
Strategic & Response Plan
20
Manuals
16
Training Material
6
Fact sheets
5
Situation Updates
4
Infographics
2
Countries / Regions
Kenya
13
Global
13
Western and Central Europe
10
Ethiopia
9
Uganda
9
Malawi
9
Nigeria
8
India
8
Tanzania
7
Africa
7
Sierra Leone
6
Rwanda
6
Liberia
5
Zambia
5
Myanmar / Burma
5
South–East Asia Region
5
Ghana
4
Nepal
4
Syria
4
Cambodia
4
Bangladesh
4
Eswatini/ Swaziland
4
Congo, Democratic Republic of
3
Zimbabwe
3
Namibia
3
Latin America and the Carribbean
3
Cameroon
2
Haiti
2
Philippines
2
Pakistan
2
Thailand
2
South Africa
2
Mozambique
2
Lesotho
2
Asia
2
Vietnam
2
Guinea
1
Jordan
1
Lebanon
1
Indonesia
1
Sudan
1
Central African Republic
1
North Macedonia
1
Ukraine
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
Poland
1
Palestine
1
Laos
1
Canada
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
115
Public Health
16
Clinical Guidelines
16
Pharmacy & Technologies
12
Key Resources
10
Capacity Building
3
Women & Child Health
3
Annual Report MEDBOX
1
Toolboxes
AMR
51
Pharmacy
31
TB
26
Malaria
19
HIV
13
COVID-19
10
Global Health Education
7
Conflict
6
NTDs
6
Planetary Health
5
Ebola & Marburg
4
Rapid Response
4
Refugee
4
Mental Health
4
Disability
2
Polio
2
Specific Hazards
1
Caregiver
1
Health Financing Toolbox
1
2.0 Rapid Response
1
Global UNIDO Project: Strengthening the local production of essential medicines in least developed and developing countries
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically
...
This interagency report provides recommendations for assuring quality of medicines during key activities of country-level procurement agencies, namely prequalification of pharmaceutical products and manufacturers; purchase of pharmaceutical products
...
Despite the considerable improvement in global health, millions of people still lack access to quality health services, including access to effective antimicrobial medicines, or are impoverished as a result of health spending. At the same time, anti
...
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
Global Action Plan on Antimicrobial Resistance
recommended
The goal of the draft global action plan is to ensure, for as long as possible, continuity of successful treatment and prevention of infectious diseases with effective and safe medicines that are quality-assured, used in a responsible way, and acces
...
In Kenya, the bacterial infections that contribute most to human disease are often those in which re-‐sistance is most evident. Examples are multidrug-‐resistant enteric bacterial pathogens such as typhoid,
...
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to medicines, making infections harder or impossible to treat,
and increasing the risk of disease spread,
...
The main objectives of these guidelines are to:
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the f ...
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the f ...
In September, 2018, the first international Medicine Quality and Public Health Conference was held at Oxford University, UK, to discuss opportunities and solutions to ensure that all people have access to affordable and quality-assured medical products. Delegates developed the short Oxford Statement
...
WHO Pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems
This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in pharmacovigilance without formal training in monitoring and evaluation. Pharmacovigilance as a medical discipline is crucial in preventing medicin
...
To understand the national situation, Ethiopia did a situation assessment, launched its first strategy in 2011, and took action to contain AMR, as detailed in the blue boxes found throughout this strategy. This updated version of the strategy was in response to the revised health and
...
Access to safe, effective and quality-assured health products and technologies is crucial for achieving universal health coverage and primary health care goals. The continued growth of the aging population; increasing burden of noncommunicable diseases; growing burden of mental health issues; climat
...
Accessed November, 2017
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
Handbook of HUMANITARIAN HEALTH CARE LOGISTICS Designing the Supply Network and Managing the Flows of Information and Health Care Goods in Humanitarian Assistance during Complex Political Emergencies
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, which considers Pharmacovigilance, an essential component of public health programs. Its intention was
...
Taking the whole of Africa approach to fighting the COVID-19 pandemic has and will continue to require coordinated efforts from multiple stakeholders from across the continent. Africa CDC would like to acknowledge the deep partnership and continued support of AUDA-NEPAD, AVAREF, WHO AFRO, the Bill a
...
